Spatiotemporal Gait Norms in Moderate-to-Advanced Parkinson’s Disease
Objective: Understanding gait abnormalities in moderate-to-advanced Parkinson’s disease (PD) is essential to enhance patient mobility and optimize clinical management [1]. This study aims to establish…Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation
Objective: To describe methodological considerations related to stakeholder engagement in community-based participatory research (CBPR) to create a dance and music-based program (DMBP) for people with…“Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
Objective: To devise a portable skid free mat bearing a combination of patterned and pictographic visual cues for freezing of gait. Background: Freezing of gait…Enhancing Parkinson’s Nurse Care with AI-Driven Remote Symptom Monitoring
Objective: This project evaluates how AI-driven continuous monitoring and wearable sensors can support Parkinson’s disease (PD) nurses in optimizing medication schedules, assessing treatment efficacy, and…Frequency and outcome of PEG tube implantations in hospitalized Parkinson’s disease patients
Objective: We aimed to investigate the frequency and outcome of percutaneous endoscopic gastrostomy (PEG) tube implantation in patients with Parkinson’s disease (PD) during United States…Foscarbidopa/Foslevodopa Therapy Improves Continuous Duration of Good ON Time and Correlated With Quality of Life in People With Parkinson’s Disease
Objective: To assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on longest consecutive duration of Good and Best ON time and association of…Exploring Clinical and Neurophysiologic Predictors of Adaptive Deep Brain Stimulation Response in Parkinson’s disease
Objective: To evaluate clinical and neurophysiologic characteristics that may predict a positive clinical response to adaptive deep brain stimulation (aDBS) in patients previously stable on…GT-02287 in Parkinson’s Disease: Interim Data from a Phase 1b Study
Objective: To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the brain-penetrant glucocerebrosidase (GCase) modulator GT-02287 in people with Parkinson’s disease with and without a…Evaluation of Local Field Potential-guided DBS-programming in a Parkinson’s disease outpatient clinic
Objective: To evaluate potential use and applicability of local field potential-guided DBS-programming under real-life conditions in a Parkinson’s disease (PD) outpatient clinic. Background: Deep brain…Effects of Dynamic Neuro-Cognitive Imagery on FOG in People with Parkinson’s Disease: a Randomized Clinical Trial
Objective: To compare the effects of an experimental intervention (EI) based on DNI with a control intervention (CI) of equal volume and intensity, excluding MP…
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 436
- Next Page »